Co-founder Hayes departs in EiRx shake-up
EiRx, which is developing a treatment for colorectal cancer, also announced a shake-up of its other top management team yesterday.
The company said the departure of Dr Hayes was part its plan for a new company structure to focus on growing revenues.





